Balance Sheet Data

ReShape Lifesciences Inc. (RSLS)

$0.8

+0.01 (+1.28%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 10.165.552.942.9622.77355.792,427.7616,565.84113,037.10771,309.50
Total Cash (%)
Account Receivables 0.490.924.102.622.8148.28329.412,247.7115,337.28104,654.01
Account Receivables (%)
Inventories 2.820.981.322.24380.15546.903,731.7725,463.77173,752.21
Inventories (%)
Accounts Payable 1.091.634.263.653.4781.43555.643,791.4125,870.71176,529.01
Accounts Payable (%)
Capital Expenditure -0.14-0.05-0.01-0.39-0.35-4.63-31.61-215.67-1,471.64-10,041.77
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.